Ranny Beatriz de Carvalho Holanda Leite
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ranny Beatriz de Carvalho Holanda Leite has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Cecília Maria de Carvalho Xavier Holanda
Laboratory of Experimental Bioavailability and Antiparasitic Tests, Department of Microbiology and Parasitology, UFRN, Natal, Brazil
1 shared publicationClarice Maux Vianna da Silva
School of Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil
1 shared publicationCláudio Bruno Silva de Oliveira
Uninassau College, Natal, Brazil
1 shared publication- Joelma Maria de Araújo Andrade
Hemocentro Dalton Cunha, Brasil
1 shared publication João Cláudio da Costa Urbano
School of Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil
1 shared publicationRenan Leopoldo Pereira Castro
School of Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil
1 shared publication
Latest Publications
- 24 July 2019
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 95 (11) , 1547-1551
Effect of toxoplasmic infection on the biodistribution of a brain radiopharmaceutical
Purpose: This study evaluated if Toxoplasma gondii infection and the drug-associated infection modifies the brain radiopharmaceutical Ethylene Cystine Diethylester Dihydrochloride (99mTc-ECD) biodistribution in mice. Materials and methods: A total of 18 mice were divided into 3 groups. Control group (C) received distilled water and 99mTc-ECD; Infected group (I) received T. gondii strain and 99mTc-ECD; Infected and Treated group (IT), in addition to infection, received association of Pyrimethamine and Sulfadiazine and 99mTc-ECD. The T. gondii strain used in this study was TgCkRrRN3. Forty minutes after administration of the 99mTc-ECD, all animals were euthanized, and blood and brain samples were isolated. The counting of the radioactivity percentage per gram of tissue (%ATI/g) was calculated, and statistical analysis was performed by t-test, with a level of significance of p < .05. Results: There was a significant increase in %ATI/g between groups C and I on brain (0.35 ± 0.02 and 0.45 ± 0.04; p = .041) and on blood (0.80 ± 0.09 and 1.14 ± 0.31; p = .049). A significant decrease in %ATI/g occurred between groups C and IT on blood (0.80 ± 0.09 and 0.54 ± 0.08; p = .001) and on brain (0.35 ± 0.02 and 0.22 ± 0.04; p = .049). Conclusions: Combined therapy of anti-Toxoplasma drugs in infected mice reduced the uptake of 99mTc-ECD, probably due to its binding to plasma proteins.
- 24 July 2019
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 95 (11) , 1547-1551
Effect of toxoplasmic infection on the biodistribution of a brain radiopharmaceutical
Purpose: This study evaluated if Toxoplasma gondii infection and the drug-associated infection modifies the brain radiopharmaceutical Ethylene Cystine Diethylester Dihydrochloride (99mTc-ECD) biodistribution in mice. Materials and methods: A total of 18 mice were divided into 3 groups. Control group (C) received distilled water and 99mTc-ECD; Infected group (I) received T. gondii strain and 99mTc-ECD; Infected and Treated group (IT), in addition to infection, received association of Pyrimethamine and Sulfadiazine and 99mTc-ECD. The T. gondii strain used in this study was TgCkRrRN3. Forty minutes after administration of the 99mTc-ECD, all animals were euthanized, and blood and brain samples were isolated. The counting of the radioactivity percentage per gram of tissue (%ATI/g) was calculated, and statistical analysis was performed by t-test, with a level of significance of p < .05. Results: There was a significant increase in %ATI/g between groups C and I on brain (0.35 ± 0.02 and 0.45 ± 0.04; p = .041) and on blood (0.80 ± 0.09 and 1.14 ± 0.31; p = .049). A significant decrease in %ATI/g occurred between groups C and IT on blood (0.80 ± 0.09 and 0.54 ± 0.08; p = .001) and on brain (0.35 ± 0.02 and 0.22 ± 0.04; p = .049). Conclusions: Combined therapy of anti-Toxoplasma drugs in infected mice reduced the uptake of 99mTc-ECD, probably due to its binding to plasma proteins.